ArticleACS medicinal chemistry letters2026

Structure-Based Drug Design of Quinoline CYP8B1 Inhibitors for the Potential Treatment of Metabolic Disease.

Amy Bittner McCracken et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.